i-Human Patients, Inc. (IHP) Company Profile

16:58 EDT 20th September 2018 | BioPortfolio

i-Human Patients, Inc. (IHP) develops virtual medical training products and services, including its flagship i-Human Patients® platform, launched in November 2012, which educators at more than 20 percent of U.S. medical schools are subscribing to or developing content on in anticipation of future use. Cloud-based and interactive, i-Human improves training outcomes and clinical protocol compliance for students, instructors, and practicing clinicians using active learning strategies and content developed by leading medical educators at more than 40 schools.

News Articles [836 Associated News Articles listed on BioPortfolio]

The First In-Human Trial of an Eye Implant Helps Patients With Glaucoma

iSTAR Medical has obtained promising results from the first-in-human trial of an eye implant, that can decrease fluid pressure in the eyes of glaucoma patients. iSTAR Medical, a Belgian biotech, has s...

Promising Gene Therapy for Visually Impaired Sheep Now Safe for Human Trials

NewsBased on promising findings, the FDA has approved clinical trials for human patients and several U.S. medical centers have already begun using this therapy to treat patients with achromatopsia.

Human insulin as safe and effective as expensive insulin analogs for patients with type 2 diabetes

Patients with Type 2 diabetes who were treated with the newer generation of insulin analog drugs did not have substantially better outcomes than those treated with less costly human insulin, according...

CDC and Kognito utilize virtual human simulation to help breast cancer patients

To better educate triple negative breast cancer patients and ultimately improve health outcomes, the CDC Division of Cancer Prevention an

Human API Teams Up with CMS to Launch FHIR-based API

Human API, the largest patient-centric health data network has announced a collaboration with the Center for Medicare and Medicaid Services (CMS) to make the new CMS Blue Button 2.0 API available thro...

First-in-human implants of FMR combo device recorded by Mardil

The first-in-human implants of the combination therapy Ventouch Triad device, involving two patients with severe type IIIb fu -More- 

New brain scanner allows patients to move freely for the first time

(Wellcome Trust) A new generation of brain scanner, that can be worn like a helmet allowing patients to move naturally whilst being scanned, has been developed by researchers at the Sir Peter Mansfiel...

The human touch in medicine: good or bad?

Humans need human touch Patients sometimes need a shoulder to cry on. When I say that, I normally mean it on a completely figurative level. However, at times, it needs to be interpreted differently. T...

Drugs and Medications [0 Results]


PubMed Articles [5218 Associated PubMed Articles listed on BioPortfolio]

Combined Infection of Human Herpes Viruses: A Risk Factor for Subsequent Colectomy in Ulcerative Colitis.

Little is known about the prevalence and pathogenicity of human herpes viruses except for cytomegalovirus (CMV) in patients with inflammatory bowel disease (IBD). The aim of this study was to determin...

Human Immunodeficiency Virus in Patients with Tuberculous meningitis: systematic review and meta-analysis.

Human immunodeficiency virus (HIV) -infected individuals are at increased risk for all forms of extrapulmonary tuberculosis (TB), including tuberculous meningitis (TBM). The current study aimed to inv...

Co-circulation of classic and novel astrovirus strains in patients with acute gastroenteritis in Germany.

In order to analyze the molecular epidemiology of human astroviruses (HAstV) in Germany, a retrospective long term study was performed to characterize circulating human astrovirus in patients with acu...

The microbiome in chronic kidney disease patients undergoing hemodialysis and peritoneal dialysis.

Chronic kidney disease (CKD) is associated with an imbalanced human microbiome due not only to CKD-associated factors such as uremia, increased inflammation and immunosuppression, but also to pharmaco...

Imaging pathological activities of human brain tissue in organotypic culture.

Insights into human brain diseases may emerge from tissue obtained after operations on patients. However techniques requiring transduction of transgenes carried by viral vectors cannot be applied to a...

Clinical Trials [3066 Associated Clinical Trials listed on BioPortfolio]

Assess the Safety and Efficacy of Individually Tailored Prophylaxis With Human-cl rhFVIII in Patients With Severe Haemophilia A

To compare the number of breakthrough bleeds under tailored prophylaxis with human cell line recombinant factor FVIII (Human-cl rhFVIII) with the historical bleeding rate from patients who...

The Tolerability,Safety,PK/PD Study of rhTPO in the Patients With Liver Function Impairment

The purpose of this study is to evaluate the tolerability, safety, pharmacokinetics and pharmacodynamics of recombinant human thrombopoietin in the patients with different degree of liver ...

Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology

A randomized, blinded, controlled trial to evaluate growth velocity and clinical outcomes in infants with single ventricle physiology fed an exclusive human milk diet prior to, and through...

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

RATIONALE: Vaccines made from certain human papillomaviruses may be able to help the body to kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of human papillomavi...

Discovering New Treatments for Asthma and COPD. A New Human Rhinvovirus for Human Challenge

A GMP rhinovirus was manufactured according to GMP and then characterised in human volunteers in the human viral challenge model.

Companies [1858 Associated Companies listed on BioPortfolio]

i-Human Patients (IHP)

i-Human Patients, Inc. develops educational and competency assessment technology for the health care professional market, including its flagship i-Human Patients® platform, lau...

i-Human Patients, Inc.

i-Human Patients, Inc. develops virtual medical training products and services, including its flagship i-Human Patients® platform, launched in November 2012, which educators at...

i-Human Patients, Inc. (IHP)

i-Human Patients, Inc. (IHP) develops virtual medical training products and services, including its flagship i-Human Patients® platform, launched in November 2012, which educat...

KaloBios Pharmaceuticals, Inc.

KaloBios Pharmaceuticals, Inc., a U.S. based, private monoclonal company, uses its biologic capabilities and its proprietary platform technology to develop first-in-class human an...

Acceptys, Inc.

Acceptys is a private biotechnology company focused on the development of human antibody therapies in cancer and infectious diseases. The Company's key strength is its ability to directly leverage the...

More Information about "i-Human Patients, Inc. (IHP)" on BioPortfolio

We have published hundreds of i-Human Patients, Inc. (IHP) news stories on BioPortfolio along with dozens of i-Human Patients, Inc. (IHP) Clinical Trials and PubMed Articles about i-Human Patients, Inc. (IHP) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of i-Human Patients, Inc. (IHP) Companies in our database. You can also find out about relevant i-Human Patients, Inc. (IHP) Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record